The key factors driving the global offsite sterilisation services market are an increase in the incidence of hospital-acquired infections, an increase in the number of surgical procedures requiring high intensity infection prevention & control, an increase in the number of government awareness programmes to ensure high degree infection prevention, an increase in the geriatric population, and an increase in the cases of chronic diseases like diabetes, cancer, heart obesity, and respiratory disorders. Additionally, the market for offsite sterilisation services is anticipated to grow as a result of rising demand for these services from hospitals and clinics, technological advancements in sterilisation equipment, and an increase in hospitals outsourcing their sterilisation needs to pharmaceutical and medical device firms.
The recession will have a significant effect on the market for offsite sterilization services. Healthcare providers may experience financial difficulties during a recession, which could result in a decline in the demand for sterilisation services as they choose more affordable in-house sterilising techniques. In addition, many healthcare professionals may delay operations and procedures that are not absolutely necessary during a recession, which may result in a decline in the need for sterilisation services. Off-site sterilisation service providers may see a decline in revenue as a result, and some facilities may even close.
Increased Demand for Medical Equipment and In-Vitro Testing to Drive Market Growth
In vitro diagnostics is the term for testing on human biological tissue or blood samples (IVD). In vitro diagnostics can be used to monitor a person's general health, identify illnesses or other abnormalities, and assist in the treatment, averting, or curing of diseases. There is a wide variety of IVDs available, ranging from straightforward self-tests for pregnancy and blood glucose monitors for diabetics to sophisticated clinical laboratory diagnostics. Other examples of IVDs include HIV tests, blood type determination, and cancer screening. Medical equipment that comes into contact with sterile bodily fluids or tissues is referred to as a critical item. These items must be clean before use in order to stop any microbial contamination from spreading disease. As a result, the market for sterilisation is growing.
Reprocessed Instrument Safety Issues Could Act as a Barrier to Market Expansion
Surgical forceps, endoscopes, and stethoscopes are some examples of reusable medical equipment. The performance and safety of recycled devices, however, are under question. A paradigm shift has occurred in the reprocessing of medical devices, with a greater emphasis now being placed on the quality management systems approach, which calls for validated sterilisation instructions from manufacturers and ongoing monitoring by reprocessing staff to ensure adequate offsite sterilisation. By reviewing premarket and postmarket data from all manufacturers and reprocessed device types, the FDA is taking action to lower the risk of infection from reusable devices that have been through processing.
By Service Technology
Based on service technology, the offsite sterilization services market is segmented into ethylene oxide sterilization, gamma sterilization, electron beam sterilization, steam sterilization, no2 sterilization and others. The ethylene oxide sterilization category dominated the market in 2022 because of its affordability and compatibility. There are, however, specialist medical supplies kits that contain devices and medications that are incompatible with radiation and other sterilising techniques. The use of ETO is anticipated to rise, propelling segment expansion over the course of the forecast period as a consequence of the increased development of health kits and the compatibility of ETO with the majority of products. Medical equipment can be sterilised using ethylene oxide gas, dry heat, radiation, moist heat (steam), moist heat (steam), moist heat (dry heat), evaporated hydrogen peroxide, and other techniques (for example, chlorine dioxide gas, vaporised peracetic acid, and nitrogen dioxide).
By End User
Based on end user, the offsite sterilization services market is segmented into hospitals, clinics, medical device companies, pharmaceutical companies, food & beverage companies, academic & research institutes and others. The hospitals category dominated the market in 2022. Sterilization is crucial in hospitals since poor sanitation could lead to the infection of both patients and staff. The desire for a healthy lifestyle and greater awareness in society are the driving forces behind the necessity for sterilising facilities. Also, the use of sterilisation has expanded quickly due to the rise in surgical procedures. As a result, it is anticipated that hospitals and clinics would hold a sizeable share of the end-user market for the duration of the forecast.
North America is projected to hold the largest share of the offsite sterilization services market over the forecast period due to a number of factors, including an increase in hospital-acquired infections, high patient registration rates, technological advancements in healthcare facilities, a strong industry presence in the region, rising government funding, increased public awareness of available technologies, and an abundance of market participants in the United States. On the other hand, the Asia Pacific offsite sterilization services market is anticipated to grow significantly because of the large population base and expanding medical tourism from various rising economies. Similarly, it is anticipated that the market for sterilising services will expand due to the rising demand for reusable medical equipment. The industry's breadth is expanding as well as top market players endeavour to penetrate untapped nations like India, China, and Korea.
LIST OF KEY COMPANIES PROFILED:
- Sterigenics U.S., LLC (Subsidiary of Sotera Health)
- Medistri SA
- E-BEAM Services, Inc
- CRETEX Medical
- Life Science Outsourcing, Inc.
- Quality Tech Services, LLC
- Prince Sterilization Services, LLC
- ClorDiSys Solutions Inc
- Pro-Tech Design and Manufacturing Inc.
- Midwest Sterilization Corporation
- Infinity Laboratories
- Blue Line Sterilization Services LLC
- MICROTROL Sterilisation Services Pvt. Ltd.
- STERILE SERVICES SINGAPORE
- BGS Beta-Gamma-Service GmbH & Co. KG
- B. Braun Sterilog Ltd (a subsidiary of B. Braun Medical)
- Surgical Holdings
- Andersen Scientific, Inc.
|Market Size in 2022
|USD 2.5 Billion
|Market Forecast in 2030
|USD 3.8 Billion
|Compound Annual Growth Rate
|Revenue (USD Million) and Volume (Kilo Tons)
|By Service Technology, By End Use and By Geography
|By Service Technology
|By End User